Loading clinical trials...
Loading clinical trials...
Clinical Trial of the Efficacy of Pegylated Interferon (PEG-IFNα-2a) Alone in Egyptian Patients With Acute Hepatitis C
Conditions
Interventions
pegylated interferon alpha2a
Locations
1
Egypt
National Hepatology and Tropical Medicine Research Institute
Cairo, Egypt
Start Date
February 1, 2003
Primary Completion Date
December 1, 2007
Completion Date
December 1, 2007
Last Updated
February 8, 2008
NCT06953479
NCT03135886
NCT05968573
NCT05042544
NCT05870969
NCT05361603
Lead Sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions